Inhibitors of human immunodeficiency virus replication
Abstract:
Compounds of Formula I, including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth:
Information query
Patent Agency Ranking
0/0